Big Buttons

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

• PFMs can get 2.5% credit card processing

  A new benefit for APC’s Pharmacy/Facility Members: They may be able to cut their credit card processing fees to just 2.5% – 2.8%. read more →

• Phoenix compounders, rise!

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Phoenix area December 5. read more →

• APC election results: directors and bylaws

  See the results of APC's elections, including four new directors and several changes to our bylaws. read more →

More News

What we know, what you can do

Many compounders recently have received a recoupment notice from ESI regarding TRICARE/CHAMPUS compounded prescriptions. (ESI is alleging that the prescriptions are fraudulent because there is no physician/patient relationship indicated.)

Join APC tomorrow for an important briefing on the issue, including suggestions for addressing it with ESI.

Thursday, June 11, 2020
5:00 PM EDT

With guests
Jeff Baird and Brad Howard of Brown and Fortunato and Ronna Hauser of NCPA

Zoom Meeting: https://us02web.zoom.us/j/84210095411
Or call in with one tap mobile: +13126266799,,84210095411#
Meeting ID: 842 1009 5411